Similarly, a positive correlation exists between the expression levels of its partners, TLR1 and TLR6, and the development of brain metastases in breast cancer patients [28], indicating the potential involvement of the TLR2 heterodimers in the metastatic spread of pre-existing tumors. Here, TLR2 is linked to breast cancer.